Ireland - English - HPRA (Health Products Regulatory Authority)

pharmaswiss ceska republika s.r.o. - dorzolamide - eye drops, solution - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmaswiss ceska republika s.r.o. - dorzolamide hydrochloride; timolol maleate - eye drops, solution - 20mg/ml+5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations

European Union - English - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - wet macular degeneration - ophthalmologicals - macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration (amd).

Malta - English - Medicines Authority

pharmaswiss Česká republika s.r.o. jankovcova 1569/2c, prague 17000, czech republic - omeprazole, diclofenac sodium - modified-release hard capsule - diclofenac sodium 75 mg omeprazole 20 mg - antiinflammatory and antirheumatic products

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

swedish orphan biovitrum ltd - methylnaltrexone bromide - solution for injection - 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bausch & lomb uk ltd - bromfenac sodium sesquihydrate - eye drops - 900microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bausch & lomb uk ltd - cefuroxime sodium - powder for solution for injection - 50mg

European Union - English - EMA (European Medicines Agency)

ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmaswiss ceska republika s.r.o. - latanoprost, timolol maleate - eye drops solution - 50mcg/ml + 5 mg/ml - beta blocking agents

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmaswiss ceska republika s.r.o. - megestrol acetate - tablet - 160 milligram(s) - progestogens; megestrol